No abstract available
Keywords:
adverse events; biological therapy; ulcerative colitis; vedolizumab.
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Colitis, Ulcerative* / drug therapy
-
Gastrointestinal Agents / adverse effects*
-
Gastrointestinal Agents / therapeutic use
-
Humans
-
Vasculitis / chemically induced*
Substances
-
Antibodies, Monoclonal, Humanized
-
Gastrointestinal Agents
-
vedolizumab